Clinical characteristics and risk factors of primary Sjögren's syndrome with liver function damage

GAO Guanli; WEI Xiaolong; SHEN Dongbei; ZHANG Yinglu; ZHANG Shurong

doi:10.16766/j.cnki.issn.1674-4152.003791

Volume 22 Issue 12

Dec. 2024

Turn off MathJax

Article Contents

Article Navigation > Chinese Journal of General Practice > 2024 > 22(12): 2033-2036

GAO Guanli, WEI Xiaolong, SHEN Dongbei, ZHANG Yinglu, ZHANG Shurong. Clinical characteristics and risk factors of primary Sjögren's syndrome with liver function damage[J]. Chinese Journal of General Practice, 2024, 22(12): 2033-2036. doi: 10.16766/j.cnki.issn.1674-4152.003791

Citation:

GAO Guanli, WEI Xiaolong, SHEN Dongbei, ZHANG Yinglu, ZHANG Shurong. Clinical characteristics and risk factors of primary Sjögren's syndrome with liver function damage[J]. Chinese Journal of General Practice, 2024, 22(12): 2033-2036. doi: 10.16766/j.cnki.issn.1674-4152.003791

Citation:

PDF( 435 KB)

Clinical characteristics and risk factors of primary Sjögren's syndrome with liver function damage

doi: 10.16766/j.cnki.issn.1674-4152.003791

GAO Guanli^{1, 2}
, WEI Xiaolong¹
, SHEN Dongbei^{1, 2}
, ZHANG Yinglu^{1, 2}
, ZHANG Shurong^{1
,
,}

1.
Department of Gastroenterology, Clinical College of Kunming Medical University, 920th Hospital of the Joint Logistics Support Force of PLA, Kunming, Yunnan 650032, China

Funds:

202201AY070001-283

202101AU070087

Received Date: 2024-02-20
Available Online: 2025-01-20

Abstract

Abstract

Objective To analyze the clinical characteristics of patients with primary Sjögren's syndrome (pSS) complicated with liver function and multi-system damage, and to explore the risk factors of liver function damage in pSS, so as to provide new basis for clinical diagnosis and treatment. Methods A total of 92 patients diagnosed with PSS and liver function damage admitted to the 920th Hospital of the Joint Logistics Support Force of PLA from January 2020 to October 2023 were selected as liver injury groups, and 92 patients with PSS patients who has no liver damage were selected as non-liver injury groups. The clinical data and auxiliary examination results of the two groups of patients were collated for comparison and analysis. Results The combination of liver damage and blood system involvement (56.5%, 52/92), joint and bone involvement (54.3%, 50/92), and thyroid involvement (23.9%, 22/92) in patients with pSS is significantly higher than in patients with pSS, however, without liver damage [34.8% (32/92), 32.6% (30/92), 8.7% (8/92), P < 0.05]. The proportion of patients with involvement of two or more systems in the liver injury group (73.9%, 68/92) is also significantly higher than that in the non-liver injury group (55.4%, 51/92, P < 0.05). The levels of CRP [6.45 (2.83, 17.10) mg/L] and WBC [6.28 (4.37, 9.51)×10⁹/L] in the pSS liver lesion group were found to be significantly higher than those in the non-liver injury group [2.45 (0.80, 8.40) mg/L, 5.31 (4.14, 6.74)×10⁹/L, P < 0.05]. The positive rates of ANA (84.8%, 78/92) and anti-SSB (50.0%, 46/92) in the pSS liver injury group were significantly higher than those in the pSS non-liver injury group [65.2% (60/92) and 28.3% (26/92), respectively, P < 0.05]. The logistic regression analysis demonstrated that elevated CRP (OR=1.037, 95% CI: 1.003-1.071, P < 0.05) and elevated WBC (OR=1.325, 95% CI: 1.139-1.542, P < 0.01), multi-system involvement (OR=2.262, 95% CI: 1.039-4.925, P < 0.05) were risk factors for liver function damage in pSS patients. Conclusion Patients with pSS who also have impaired liver function are frequently accompanied by multiple system impairment. Elevated CRP and WBC levels, in conjunction with multi-system involvement, constitute risk factors for pSS-related liver dysfunction.
- Sjögren's syndrome,
- Liver function impairment,
- Multisystem damage

FullText(HTML)

References(23)

References

[1]	QIN B, WANG J, YANG Z, et al. Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis[J]. Ann Rheum Dis, 2015, 74(11): 1983-1989. doi: 10.1136/annrheumdis-2014-205375
[2]	段维佳, 李淑香, 吕婷婷, 等. 结缔组织病与肝损伤[J]. 中华肝脏病杂志, 2022, 30(4): 357-361. doi: 10.3760/cma.j.cn501113-20220317-00116 DUAN W J, LI S X, LYU T T, et al. Connective tissue diseases and the liver injury[J]. Chinese Journal of Hepatology, 2022, 30(4): 357-361. doi: 10.3760/cma.j.cn501113-20220317-00116
[3]	梅永君, 李志军. 干燥综合征的诊断与治疗[J]. 中华全科医学, 2020, 18(6): 890-891. http://www.zhqkyx.net/article/id/7789ea4e-535d-4c41-9dac-467ceb3d00a2 MEI Y J, LI Z J. Diagnosis and treatment of Sjogren's syndrome[J]. Chinese Journal of General Practice, 2020, 18(6): 890-891. http://www.zhqkyx.net/article/id/7789ea4e-535d-4c41-9dac-467ceb3d00a2
[4]	BOTH T, DALM V A, VAN HAGEN P M, et al. Reviewing primary Sjögren's syndrome: beyond the dryness-from pathophysiology to diagnosis and treatment[J]. Int J Med Sci, 2017, 14(3): 191-200. doi: 10.7150/ijms.17718
[5]	林磊. 原发性干燥综合征肝脏损害临床特点及转归[D]. 合肥: 安徽医科大学, 2018. LIN L. Clinical characteristics and prognosis of liver damage in primary Sjogren's syndrome[D]. Hefei: Anhui Med Univ, 2018.
[6]	CORNEC D, JOUSSE-JOULIN S, PERS J O, et al. Contribution of salivary gland ultrasonography to the diagnosis of Sjögren's syndrome: toward new diagnostic criteria?[J]. Arthritis Rheum, 2013, 65(1): 216-225. doi: 10.1002/art.37698
[7]	MARIETTE X, CRISWELL L A. Primary Sjögren's syndrome[J]. N Engl J Med, 2018, 378(10): 931-939. doi: 10.1056/NEJMcp1702514
[8]	CHOUDHRY H S, HOSSEINI S, CHOUDHRY H S, et al. Updates in diagnostics, treatments, and correlations between oral and ocular manifestations of Sjögren's syndrome[J]. Ocul Surf, 2022, 26: 75-87. doi: 10.1016/j.jtos.2022.08.001
[9]	BALDINI C, PEPE P, QUARTUCCIO L, et al. Primary Sjögren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients[J]. Rheumatology(Oxford), 2014, 53(5): 839-844. doi: 10.1093/rheumatology/ket427
[10]	BRITO-ZERON P, ACAR-DENIZLI N, NG W F, et al. Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome[J]. Rheumatology(Oxford), 2020, 59(9): 2350-2359. doi: 10.1093/rheumatology/kez578
[11]	陈树, 陈洁, 常新, 等. 原发性干燥综合征合并血液系统受累的危险因素分析[J]. 实用临床医药杂志, 2023, 27(3): 91-96, 102. CHEN S, CHEN J, CHANG X, et al. Analysis of risk factors for primary Sjogren's syndrome with hematological involvement[J]. J Pract Clin Med, 2023, 27(3): 91-96, 102.
[12]	BRITO-ZERON P, THEANDER E, BALDINI C, et al. Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations[J]. Expert Rev Clin Immunol, 2016, 12(2): 137-156. doi: 10.1586/1744666X.2016.1109449
[13]	JARA L J, NAVARRO C, BRITO-ZERON MDEL P, et al. Thyroid disease in Sjögren's syndrome[J]. Clin Rheumatol, 2007, 26(10): 1601-1606. doi: 10.1007/s10067-007-0638-6
[14]	颜淑敏, 张文, 李梦涛, 等. 原发性干燥综合征573例临床分析[J]. 中华风湿病学杂志, 2010, 14(4): 223-227. doi: 10.3760/cma.j.issn.1007-7480.2010.04.003 YAN S M, ZHANG W, LI M T, et al. Clinical analysis of 573 cases of primary Sjogren's syndrome[J]. Chin J Rheumat, 2010, 14(4): 223-227. doi: 10.3760/cma.j.issn.1007-7480.2010.04.003
[15]	SAMBATARO D, SAMBATARO G, DAL BOSCO Y, et al. Present and future of biologic drugs in primary Sjögren's syndrome[J]. Expert Opin Biol Ther, 2017, 17(1): 63-75. doi: 10.1080/14712598.2017.1235698
[16]	ZHANG K, YU X, ZHANG Y, et al. Identification of key genes in salivary gland in Sjögren's syndrome complicated with Hashimoto thyroiditis: common pathogenesis and potential diagnostic markers[J]. Medicine(Baltimore), 2023, 102(39): e35188. DOI: 10.1097/MD.0000000000035188.
[17]	ANAYA J M, RESTREPO-JIMÉNEZ P, RODRÍGUEZ Y, et al. Sjögren's syndrome and autoimmune thyroid disease: two sides of the same coin[J]. Clin Rev Allergy Immunol, 2019, 56(3): 362-374. doi: 10.1007/s12016-018-8709-9
[18]	POPOV Y, SALOMON-ESCOTO K. Gastrointestinal and hepatic disease in Sjögren syndrome[J]. Rheum Dis Clin North Am, 2018, 44(1): 143-151. doi: 10.1016/j.rdc.2017.09.010
[19]	EBERT E C. Gastrointestinal and hepatic manifestations of Sjögren syndrome[J]. J Clin Gastroenterol, 2012, 46(1): 25-30. doi: 10.1097/MCG.0b013e3182329d9c
[20]	NEGRINI S, EMMI G, GRECO M, et al. Sjögren's syndrome: a systemic autoimmune disease[J]. Clin Exp Med, 2022, 22(1): 9-25. doi: 10.1007/s10238-021-00728-6
[21]	KIM Y J, CHOE J, KIM H J, et al. Long-term clinical course and outcome in patients with primary Sjögren syndrome-associated interstitial lung disease[J]. Sci Rep, 2021, 11(1): 12827. DOI: 10.1038/s41598-021-92024-2.
[22]	王建军, 吕群, 龚玲, 等. 原发性干燥综合征合并间质性肺病患者临床与影像特点分析[J]. 中华全科医学, 2019, 17(8): 1275-1278. doi: 10.16766/j.cnki.issn.1674-4152.000920 WANG J J, LYU Q, GONG L, et al. Analysis of clinical and imaging characteristics of patients with primary Sjogren's syndrome complicated with interstitial lung disease[J]. Chin Gen Med, 2019, 17(8): 1275-1278. doi: 10.16766/j.cnki.issn.1674-4152.000920
[23]	冯大莺, 陈华英, 潘虹英, 等. 血浆proBDNF水平与原发性干燥综合征伴抑郁症状的相关性研究[J]. 昆明医科大学学报, 2023, 44(6): 54-58. FENG D Y, CHEN H Y, PAN H Y, et al. The correlation between plasma proBDNF level and primary Sjogren's syndrome with depressive symptoms[J]. Academic J Kun Ming Med Univ, 2023, 44(6): 54-58.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Tables(6)

Get Citation

PDF

XML

Article Metrics

Article views (10) PDF downloads(2)

Clinical characteristics and risk factors of primary Sjögren's syndrome with liver function damage

doi: 10.16766/j.cnki.issn.1674-4152.003791

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Clinical characteristics and risk factors of primary Sjögren's syndrome with liver function damage

doi: 10.16766/j.cnki.issn.1674-4152.003791

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content